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ABSTRACT
Introduction Achieving glycemic targets and optimizing 
quality of life (QoL) are important goals of type 1 diabetes 
care. Hypoglycemia is a common barrier to achieving 
targets and can be associated with significant distress. 
However, the impact of hypoglycemia on QoL is not fully 
understood. The aim of this study was to explore how 
adults with type 1 diabetes are impacted by hypoglycemia 
in areas of life that are important to their overall QoL.
Research design and methods Participants responded 
to a web- based qualitative survey involving a novel ‘Wheel 
of Life’ activity. Responses were analyzed using reflexive 
thematic analysis.
Results The final sample included 219 adults with type 
1 diabetes from Denmark, Germany, the Netherlands, and 
the UK. They had a mean±SD age of 39±13 years and 
diabetes duration of 20±14 years. Participants identified 
eight areas of life important to their overall QoL, including 
relationships and social life, work and studies, leisure and 
physical activity, everyday life, sleep, sex life, physical 
health, and mental health. Participants reported emotional, 
behavioral, cognitive, and social impacts of hypoglycemia 
within domains. Across domains, participants described 
interruptions, limited participation in activities, exhaustion, 
fear of hypoglycemia, compensatory strategies to prevent 
hypoglycemia, and reduced spontaneity.
Conclusions The findings emphasize the profound impact 
of hypoglycemia on QoL and diabetes self- care behaviors. 
Diabetes services should be aware of and address the 
burden of hypoglycemia to provide person- centered care. 
Clinicians could ask individuals how hypoglycemia affects 
important areas of their lives to better understand the 
personal impact and develop tailored management plans.
INTRODUCTION
Hypoglycemia remains a common barrier to 
optimal glycemic management for adults with 
type 1 diabetes, despite advances in insulin 
analogs, insulin delivery devices, and glucose 
monitoring devices.1 2 Episodes can be 
frightening and life- threatening, with some 
resulting in loss of consciousness, seizure, 
and rarely, sudden death.3 Adults with type 
1 diabetes report that hypoglycemia impairs 
their sleep quality, work productivity, driving 
safety, and overall quality of life (QoL).4 5 
Significance of this study
What is already known about this subject?
 ► Hypoglycemia is common and burdensome among 
adults with type 1 diabetes, yet its impact on quality 
of life (QoL) is not fully understood.
What are the new findings?
 ► Adults with type 1 diabetes experience emotional, social, 
cognitive, and behavioral impacts of hypoglycemia on 
their relationships, work/studies, leisure, everyday life, 
sleep, sex life, and physical/mental health.
 ► There are short- term impacts of hypoglycemic epi-
sodes as well as persistent impacts of living with the 
risk of hypoglycemia.
 ► Hypoglycemic episodes caused interruptions, limited 
participation in activities, reduced performance on ac-
tivities/tasks, exhaustion, and concentration difficulties.
 ► In terms of living with the risk of hypoglycemia, par-
ticipants feared and were preoccupied with hypo-
glycemia, maintained higher glucose and frequently 
checked their glucose to prevent hypoglycemia, and 
were limited in their spontaneity.
How might these results change the focus of 
research or clinical practice?
 ► Healthcare professionals’ need to understand the 
multifaceted impact of hypoglycemia on QoL and 
diabetes self- management.
 ► Clinicians could ask individuals how hypoglycemia 
affects important areas of their lives to better un-
derstand the personal impact, then facilitate access 
to tools and develop tailored hypoglycemia manage-
ment plans accordingly.
 ► Further research is needed to determine whether 
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QoL is increasingly emphasized as an important health 
outcome, with optimization of QoL a fundamental goal 
of diabetes care.6 It is a subjective and multi- faceted 
construct encompassing physical, psychological, and 
social factors.7 While the impact of hypoglycemia on QoL 
is recognized in research and clinical practice, it is not 
well understood.7
Previous studies of the impact of hypoglycemia have 
focused almost exclusively on psychological outcomes, 
namely fear of hypoglycemia.8 This restricts our under-
standing of the burden to the impact on emotional 
aspects of QoL and limits our understanding of other 
potentially important domains (eg, work or relation-
ships). In addition, past research has used measures that 
assess other constructs (eg, health status) and applied 
fixed frameworks of QoL that may not be relevant to 
study participants.9
While qualitative studies have focused on experiences 
of impaired hypoglycemia awareness and the challenges 
imposed by hypoglycemia,2 10 no study has investigated 
how adults with type 1 diabetes are affected by hypogly-
cemia in QoL domains that are personally important to 
them. The aim of this study was to explore the impact 
of hypoglycemia on QoL by inviting adults with type 1 
diabetes to describe how important areas of their lives 
are affected by hypoglycemia. This study was conducted 
across four European countries (Denmark, Germany, the 
Netherlands, and the UK), with the secondary aim of 
examining between- country differences in hypoglycemia 
impacts.
RESEARCH DESIGN AND METHODS
This study involved a web- based qualitative survey.
Participants
In each of the target countries, the study was advertised 
in diabetes clinics, on social media, and via e- newsletters 
distributed by diabetes associations. Individuals were 
eligible to participate if they were: ≥18 years old, self- 
reporting a diagnosis of type 1 diabetes, and living in one 
of the target countries. Sample size targets were N=50 in 
each country, based on previous studies of people with 
diabetes achieving conceptual saturation with similar 
sample sizes.11
Materials
The survey involved a ‘Wheel of Life’ activity that asked 
participants to identify areas of life that are important 
to their overall QoL, then describe how hypoglycemia 
affects those areas they identified (see figure 1). This 
activity has been implemented as an interview method 
in past research on the impact of diabetes on QoL.12 13 
The method was adapted to include written instructions 
that enabled participants to complete the activity online 
without interviewer facilitation.
Demographic and clinical characteristics were assessed 
using validated measures and study- specific items. Eight 
items of the Hypoglycaemia Awareness Questionnaire14 
assessed self- reported frequency, severity, and awareness of 
hypoglycemia in the past 12 months. The single- item Gold 
Score15 assessed self- reported hypoglycemia awareness. The 
six- item Worry subscale of the Hypoglycemia Fear Survey 
Short Form16 assessed fear of hypoglycemia. Since the study 
was conducted during the COVID-19 pandemic, a nine- item 
adaptation of the Diabetes Attitudes, Wishes, and Needs 2 
Impact of Diabetes Profile (DIDP)17 was included to assess 
the impact of the pandemic on diabetes and various aspects 
of QoL. Five adults with type 1 diabetes piloted the survey 
to verify the readability, relevance, and importance of survey 
questions. English survey content was then translated into 
Danish, Dutch, and German in accordance with best prac-
tice guidelines.18
Data collection
The survey was hosted on REDCap,19 an online survey plat-
form accessible via computer, tablet, or smartphone. Partic-
ipants responded to screening questions to determine their 
eligibility. Eligible participants then reviewed an Information 
Sheet and gave their consent to participate anonymously by 
selecting checkboxes. Purposive sampling was used to recruit 
equal numbers of participants in each country and partici-
pants reporting the presence or absence of severe hypogly-
cemia in the past year. Once sample size targets were met 
for each group, data were checked for completeness and the 
survey was closed.
Data analysis
Survey records were imported into SPSS V.22 and NVivo 
V.12. Non- English records were translated via Google 
Translate then reviewed by native speakers of the orig-
inal language for semantic equivalence between original 
and translated versions. Translated free- text responses 
were analyzed using reflexive thematic analysis. Two 
researchers (HC and MVJ) developed the coding frame-
work with consultation from coauthors. HC coded 100% 
of the dataset and MVJ coded 20% for comparison. 
Researchers generated initial codes by familiarizing 
themselves with free- text responses then summarizing 
data extracts line- by- line within QoL domains. Extracts 
were only coded if they were meaningful and able to 
be interpreted, usually more than one word or short 
responses. Codes were observed to be qualitatively similar 
between countries; therefore, responses were pooled 
for theme development. Semantically related codes 
were clustered to develop themes within QoL domains. 
Themes were reviewed for goodness- of- fit, coherence, 
and discrimination from other themes. Researchers 
determined whether extracts within domains reflected 
emotional, behavioral, cognitive, or social impacts to 
evaluate the impact of hypoglycemia across these areas 
of functioning. Descriptive statistics were calculated 
for demographic and clinical variables. Between- group 
differences (by gender, country, and experience of 
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RESULTS
Of the 237 survey respondents, 18 did not attempt the 
‘Wheel of Life’ and were excluded. Excluded participants 
were more likely to be men, engaged in unpaid work, 
and report more worry about hypoglycemia, compared 
to included participants (online supplemental table 1).
Sample characteristics
The final sample included 219 adults with type 1 
diabetes. They had a mean±SD age of 39±13 years and 
diabetes duration of 20±14 years. Eighty- three per cent 
(n=182) were women. Sixty- nine per cent (n=151) 
were living with a spouse or partner. Forty- two per cent 
(n=92) were working full- time. Seventy- seven per cent 
(n=170) were using flash glucose monitoring or contin-
uous glucose monitoring (CGM). Fifty- three per cent 
(n=116) were using an insulin pump. Forty- seven per 
cent (n=102) were using multiple daily injections. Partic-
ipants reported a median (IQR) of 4 (2-6) hypoglycemic 
episodes of any severity in the past week. Thirty- two per 
cent (n=70) of the sample reported at least one severe 
episode in the past year. Frequency of severe hypogly-
cemia in the past year ranged from 1 to 240 episodes 
per person, with a total of 624 episodes across those 70 
participants reporting at least one episode. Thirty- nine 
per cent (n=87) reported impaired awareness of hypo-
glycemia (IAH) (Gold Score >4).15 Fifty- one per cent 
(n=123) reported a comorbid physical or mental health 
diagnosis. Mean composite scores on the adapted DIDP 
indicated that overall QoL had been ‘slightly negatively’ 
impacted by the COVID-19 pandemic (online supple-
mental table 2).
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QoL domains
Using the 'Wheel of Life', participants identified a 
mean±SD of 4±1 areas of life important to their overall 
QoL. Table 1 presents the eight QoL domains identified 
across responses, including the number of times each 
domain was nominated. Women were more likely than 
men to nominate relationships as an important area of 
life. There were no further differences in the number of 
times each domain was nominated by gender, country, 
or experience of severe hypoglycemia in the past year 
(online supplemental tables 3–5).
Impact of hypoglycemia on QoL
Table 2 presents the reported impact of hypoglycemia on 
QoL domains. The length of free- text responses ranged 
from 1 to 382 words, with a median of 24 words. Of the 
859 responses, 74% (n=635) were meaningful and able to 
be interpreted. In five of the eight domains, participants 
indicated that every area of functioning was affected by 
hypoglycemia. Participants rarely reported that QoL 
domains were unaffected by hypoglycemia (5%; n=29 of 
meaningful responses).
Participants from Germany were more likely than 
participants from other countries to report an impact on 
their leisure and physical activity. Participants from the 
Netherlands were more likely to report mental health 
impacts. Women were more likely than men to report an 
impact on their work or studies. Participants who expe-
rienced severe hypoglycemia in the past year were more 
likely than participants who had not experienced severe 
hypoglycemia in the past year to report an impact on 
their sex life. There were no further differences between 
groups (online supplemental tables 6–8). Box 1 presents 
participants’ quotations to illustrate themes.
Relationships and social life
Disrupted quality time
Participants explained that hypoglycemia and its after- 
effects limited their ability to interact with family and 
friends. During hypoglycemia, they found it difficult 
to speak, respond, and ‘connect emotionally with what 
people are saying’. Some felt embarrassed about their 
‘childish’, ‘resistant’, or drunken- like behavior during 
hypoglycemia. They cancelled plans or interrupted 
activities to treat hypoglycemia, which was annoying 
for them and meant that others had to wait for them. 
Some were unable to enjoy meals with friends due to 
having eaten to treat hypoglycemia before the meal. 
Participants felt ‘drained’ following hypoglycemia and 
lacked energy for interaction. They felt moody and 
irritable, which sometimes resulted in arguments or 
‘being unfairly angry’ towards their children. Some 
explained that their partners became frustrated with 
them for recurrences. Participants were worried about 
burdening others, particularly family members who 
helped with treatment or were inconvenienced by 
interruptions (eg, sensor alarms), so hypoglycemic 
events were ‘downplayed’ or treated discreetly to avoid 
worrying or bothering others.
Reduced ability to parent
Some participants found it difficult to take care of their 
children during hypoglycemia, as they had to ‘attend to 
their own needs first’. They felt unable to fulfill their usual 
role and responsibilities due to hypoglycemia, and some-
times had to relinquish care of their children to their 
spouse/partner. Some stated that their children had 
‘treated hypos for them’ and ‘taken care of them’, which was 
distressing for parents. Some expressed concerns about 
taking care of their child without another adult present, 
due to the risk of hypoglycemia.
Fears and compensatory strategies
Participants feared hypoglycemia occurring in the 
company of others and felt uncomfortable with others 
potentially witnessing episodes. Consequently, they 
accepted less social invitations, participated less actively 
in certain activities, and maintained higher glucose 
levels for social events. Some felt ‘trapped’, ‘paralyzed’, 
and completely unable to participate in social events 
due to the risk of hypoglycemia. They reported a lack 
Table 1 QoL domains important to overall QoL among adults with type 1 diabetes
QoL domain Number of references* Description
Relationships and social life 233 Relationships with spouses/partners, children, other family 
members, and friends
Work and studies 176 Work, school/university, and other vocational activities
Leisure and physical activity 175 Sports, exercise, travel/vacation, and other hobbies
Everyday life 137 Driving, eating, household duties, and other functional activities
Sleep 80 Bedtime routine, sleep, and next- day functioning
Sex life 34 Sexual activity and intimacy
Physical health 24 Specific aspects of health (eg, pregnancy)
Mental health 10 Mood fluctuations and emotional difficulties
*Domains may have been nominated multiple times across the ‘Wheel of Life’ by a single participant (eg, ‘work meetings’, ‘working life’, and 
‘talks with colleagues’), hence the number of references for a QoL domain may exceed the total number of participants.
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of flexibility in making plans, with outings needing to 
be well- organized rather than spontaneous to mitigate 
risk. By contrast, some explained that they felt able to 
manage the risk of hypoglycemia because they were 
well- supported by family and friends.
Work and studies
Reduced productivity and performance
Participants experienced reduced productivity or perfor-
mance at work or school/university due to hypogly-
cemia. They described exhaustion and concentration 
difficulties due to both nocturnal episodes and episodes 
that occurred during work hours. Difficulties with focus, 
alertness, and ‘mental sharpness’ were linked to suboptimal 
execution of tasks (‘overlooking things’, ‘making mistakes’, 
or ‘missing deadlines’). They often interrupted tasks to 
manage hypoglycemia, which was annoying for them. 
They checked their glucose and treated hypoglycemia in 
secret to avoid unwanted attention or negative evaluation 
from colleagues. Participants described long recovery 
periods and felt pressured to resume tasks despite feeling 
unwell. They sometimes arrived late to work or took sick 
leave following nocturnal hypoglycemia.
Fears and compensatory strategies
Participants feared hypoglycemia at work and were 
worried about appearing unprofessional, frightening 
others, or embarrassing themselves. They maintained 
Table 2 Impact of hypoglycemia on QoL domains: themes, number of references (N), described impacts, and areas of 
functioning affected
Domains/Themes N Emotional Behavioral Cognitive Social
Relationships and social life 141 X X X X
Disrupted quality time 117 Interrupted/cancelled activities, irritability/conflict, worry about burdening others, fatigue, 
unable to interact with others
Reduced ability to parent 27 Unable to fulfil roles and responsibilites, unable to take care of children
Fears and compensatory strategies 25 Lack spontaneity, less active participation, maintain higher glucose levels
Work and studies 148 X X X X
Reduced productivity or performance 105 Fatigue, poor concentration, interrupted/stopped tasks, fear negative evaluation from 
colleagues, late arrival/sick leave
Fears and compensatory strategies 43 Fear of hypoglycemia, maintain higher glucose levels, check glucose levels frequently
Limited employment prospects 10 Difficult to get/keep job, work part- time for less pressure, unable to pursue certain job 
prospects
Leisure and physical activity 122 X X X X
Fears and limited spontaneity 71 Limited/ceased participation, lack spontaneity, fear of hypoglycemia, maintain higher glucose 
levels, check glucose levels repeatedly
Interrupted, discontinued, or cancelled activities 61 Breaks taken, activities cut short/cancelled, reduced performance, fatigue, concentration 
difficulties
Everyday life 89 X X X X
Limited driving freedom 47 Fear of hypoglycemia, maintain higher glucose levels, check glucose levels frequently, unable 
to drive/delayed in starting trip
Day- to- day burdens 30 Carry treatments/equipment, interrupted/discontinued household duties, financial burden of 
treatments
Limited dietary freedom 12 Food choices dictated by glucose levels, unable to enjoy foods associated with hypoglycemia
Sleep 62 X X X X
Fears and compensatory strategies 28 Fear hypoglycemic coma/not waking up, maintain higher glucose levels, set alarms to check 
glucose levels overnight
Disrupted sleep 24 Multiple interruptions, delayed sleep onset, unable to return to sleep, nightmares, rebound 
hyperglycemia
Next- day fatigue 16 Exhaustion, bad moods, and impaired functioning
Sex life 24 X X   X
Postponed, interrupted, or discontinued sexual 
activity
23 Interrupted/discontinued sex, limited ability to enjoy sex, worry about disappointing partner
Reduced spontaneity 4 Fear of/preoccupation with hypoglycemia during sex
Physical health 14 X X     
Other aspects of health negatively affected 14 Weight gain/unable to lose weight, comorbidities exacerbated, pregnancy complications
Mental health 35 X X   X
Emotional difficulties 11 Negative emotional states, ashamed/angry with self for recurrences, disordered eating 
behaviors exacerbated
Persistent stress 24 Fear of/preoccupation with the risk of hypoglycemia, less carefree
Extracts may be coded to more than one subtheme, thus N for themes may exceed the sum of subtheme N. Emotional impacts=effects on mood. Behavioral impacts=effects on 
actions or conduct. Cognitive impacts=effects on thinking or decision- making. Social impacts=effects on interactions with others.
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higher glucose levels and checked their glucose frequently 
to prevent hypoglycemia. Some commented on the 
advantages of CGM for discreet glucose checking and 
hypoglycemia prevention at work.
Limited employment prospects
Some participants were self- employed, unemployed, 
retired, or felt limited in pursuing their ‘dream job’. Some 
explained that it was difficult to get or maintain a job due 
to the risk of hypoglycemia. Others opted for part- time 
work for fewer hours and ‘less work pressure’.
Leisure and physical activity
Interrupted, discontinued, or canceled activities
Participants ‘cut short’ or ‘called off’ sports, exercise, and 
leisure activities due to hypoglycemia. Some felt unable 
to work out as frequently as they wanted. Fatigue and 
concentration difficulties further contributed to reduced 
performance. They noted that hypoglycemia often 
restricted them and ‘takes the fun out things’, which was 
frustrating for them. Participants explained that the need 
to consume additional calories to manage (the risk of) 
hypoglycemia ‘makes exercise seem pointless’.
Fears and limited spontaneity
Participants feared hypoglycemia during physical activity 
and stated that ‘activities are difficult to implement sponta-
neously’. Rigorous planning was required to account for 
glucose fluctuations that occurred with exercise. Some 
attempted to prevent hypoglycemia by maintaining higher 
glucose levels and checking their glucose frequently, 
which could be disruptive and ‘defeat the purpose’ of the 
activity (eg, walking for relaxation). Some chose low- key 
or less physically active pursuits to prevent hypoglycemia. 
Others participated less often in certain activities (eg, 
leading church events) due to fear of hypoglycemia.
Everyday life
Limited driving freedom
Participants experienced driving as stressful due to fear 
of hypoglycemia while driving. They attempted to offset 
their fears by checking their glucose frequently and main-
taining higher glucose levels while driving. Trips were 
delayed or interrupted due to hypoglycemia, which was 
annoying for them and meant that they had to cancel or 
arrive late to appointments. Some had been involved in 
a car accident due to hypoglycemia or had experienced 
discrimination when renewing their driver’s license. 
Some mentioned that CGM had offered greater safety, 
security, and flexibility with driving.
Day-to-day burdens
Participants described the burden of constantly carrying 
hypoglycemia treatments and equipment. They felt frus-
trated when household duties had to be interrupted, 
postponed, or discontinued due to hypoglycemia. Partic-
ipants were burdened by the financial costs associated 
with hypoglycemia, including treatments and diabetes 
supports not covered by insurance (eg, service dog).
Limited dietary freedom
Participants often had to ingest carbohydrates to treat 
hypoglycemia despite not being hungry, which conflicted 
with their healthy eating/weight loss goals and enjoyment 
Box 1 Participant descriptions of the impact of 
hypoglycemia on QoL domains
Relationships and social life
“My children have had to treat my hypos. Young children have had to 
see me shake uncontrollably and be very weak until I recover.” (Woman)
“You do not want to end up as a burden to others if you go and lose con-
trol, which dulls the desire to interact with others and be participatory/self- 
forgetting.” (Man)
Work and studies
“Hypoglycaemia reduces my attention and ability to think clearly, so 
mistakes can happen. This can be very uncomfortable, especially in 
contact with customers.” (Man)
“I get so nervous about getting low that I check very often at work. I 
fear what my employer thinks and whether they see me in a worse 
position than my colleagues.” (Woman)
Leisure and physical activity
“It is annoying when sport has to be interrupted all the time and you cannot, 
like healthy people, just do what you want for as long as you want.” (Man)
“I can do craft hobbies and reading because they are low intensity and 
don’t cause hypos. I would like to be brave one day and try new hobbies 
if I can get over my fears.” (Woman)
Everyday life
“Driving long distances without a hypo is almost impossible. To be late for an 
appointment because of a hypo is simply uncomfortable.” (Woman)
“To do something spontaneously at short notice is impossible, because 
I have to prepare all scenarios and drag luggage along with me.” (Man)
“I often make choices about what I eat based on my values. With hypos, 
I eat things that I don’t want. Then the sword of Damocles hangs over 
my head because I know that it will result in a hypo or hyper.” (Woman)
Sleep
“I run high at night because I’m afraid I will have a hypo in my sleep 
and not wake up.” (Woman)
“The next day, I am useless. I am constantly behind the facts and feel 
lethargic and empty.” (Man)
Mental health
“When I have low blood sugar, I am incredibly hard on myself and 
spend a lot of energy scolding myself!” (Woman)
“The stress associated with anticipating hypos is debilitating. I often 
get worked up about this and I feel really anxious/frustrated that my life 
is dictated by my blood sugar.” (Woman)
Sex life
“Hypoglycemia destroys the ability to have sex and the sexual activity 
itself can induce hypoglycemia. There are few situations that are more 
despairing and at times humiliating. You are reminded that your body 
is a machine that has lost the ability to maintain itself and that you are 
the controller who at this very unfortunate time has lost control.” (Man)
Physical health
“I’m afraid of comorbidities. Will I do everything I want? Can I become 
a mother and what type? What can I offer those around me? Why can’t 
I have the job I have dreamed of all my life? I have such thoughts every 
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of shared meals. Food choices were often dictated by 
glucose levels and some previously enjoyed foods had 
become too closely associated with hypoglycemia treat-
ment. Some limited their alcohol intake due to fear of 
hypoglycemia and ‘losing control’.
Sleep
Fears and compensatory strategies
Participants were afraid of hypoglycemic coma or not 
waking up from sleep due to hypoglycemia. Many 
attempted to prevent hypoglycemia by maintaining 
higher glucose levels overnight and setting alarms to 
check their glucose throughout the night. Participants 
felt tense when falling asleep due to the risk of hypogly-
cemia. Many commented on the benefits of CGM for 
alleviating fear and alerting them to low glucose. Some 
mentioned that CGM alarms “didn’t always wake them 
up” or were too disruptive, which led some to switch off 
alarms.
Disrupted sleep
Participants and their spouses/partners experienced 
multiple sleep interruptions due to hypoglycemia, 
including sensor alarms, delayed sleep onset due to 
glucose fluctuations, difficulties falling asleep after 
waking up with hypoglycemia, nightmares, and rebound 
hyperglycemia due to overtreatment of hypoglycemia 
and associated counterregulation.
Next-day fatigue
Participants felt unrested and ‘drained’ following 
nocturnal hypoglycemia and sleep disruptions. Next- day 
fatigue was associated with ‘bad moods’ and impaired 
functioning. Some mentioned headaches and ‘feeling 
hungover’, which was associated with concentration diffi-
culties and ‘possible incapacity for work’.
Sex life
Sexual activities were often postponed, interrupted, or 
discontinued due to hypoglycemia. Some participants 
were ‘too tired’ or ‘not receptive’ to sexual advances following 
hypoglycemia. Others were unable to achieve climax 
and some men reported difficulties getting an erection. 
Consequently, ‘lust or pleasure dissipated’ and they felt ‘bad’, 
‘frustrated’, ‘embarrassed’, ‘insecure’, or ‘humiliated’. Partici-
pants were worried about disappointing or frightening 
their partner, particularly in a new relationship and/or 
when their partner was unfamiliar with hypoglycemia. 
Since sex often induced hypoglycemia, participants 
lacked spontaneity with sex or were preoccupied with 
fear of hypoglycemia during sex.
Physical health
Due to consuming additional calories to treat hypogly-
cemia, some had gained weight or found it difficult to 
lose weight, and felt uncomfortable with their body. 
Some women explained that, prior to pregnancy, it was 
difficult to achieve recommended hemoglobin A1c levels 
because they were too scared to maintain glucose levels 
in such a low range or overtreated hypoglycemia and 
experienced rebound hyperglycemia. Some mentioned 
that comorbidities (eg, multiple sclerosis) were exacer-
bated by hypoglycemia. Participants explained that they 
were fearful of long- term health complications due to 
frequent hypoglycemia and/or rebound hyperglycemia.
Mental health
Emotional difficulties during and after episodes
Participants described many emotional states during 
and after hypoglycemia, including irritability, sadness, 
helplessness, and general moodiness. They felt ashamed or 
angry with themselves for recurrences. Some explained 
that hypoglycemia exacerbated stress and pre- existing 
disordered eating behaviors, whereby they suspended 
or turned off their insulin pumps and/or skipped meals 
to compensate for calories consumed for hypoglycemia 
treatment.
Persistent emotional impacts of hypoglycemia
Participants described a pervasive sense of anxiety and 
‘tenseness’ related to the ever- present threat of hypogly-
cemia. They reported an enduring fear of hypoglycemia 
between episodes. Many were preoccupied with hypo-
glycemia and always ‘working on’ hypoglycemia, at the 
expense of enjoying leisure activities and quality time 
with others. Participants commented that they no longer 
had ‘peace of mind’: “Never again will I be carefree”.
DISCUSSION
This web- based qualitative study is the first to explore 
the impact of hypoglycemia on areas of life that adults 
with type 1 diabetes identify as important to their overall 
QoL. The findings show that hypoglycemia affects many 
areas of life important to adults with type 1 diabetes, 
including their relationships and social life, work and 
studies, leisure and physical activity, everyday life, sleep, 
sex life, physical health, and mental health. Partici-
pants described the short- term impacts of hypoglycemic 
episodes as well as the persistent impacts of living with the 
risk of hypoglycemia. Common reports across domains 
relating to hypoglycemic episodes were interruptions, 
limited participation in activities, reduced performance, 
exhaustion, and concentration difficulties. Common 
reports relating to living with the risk of hypoglycemia 
were fear of and preoccupation with hypoglycemia, main-
tenance of higher glucose and frequent glucose checking 
to prevent hypoglycemia, and limited spontaneity. These 
findings were largely consistent across four European 
countries.
Participants experienced emotional, behavioral, cogni-
tive, and social impacts in most QoL domains, which 
indicates that hypoglycemia affects many areas of func-
tioning, including the way individuals think, feel, behave, 
and interact with others. In addition to reported impacts 
on mental health, participants indicated that hypogly-
cemia affected their emotional functioning in all other 
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pervasive impact on emotional well- being. Fear of hypo-
glycemia was mentioned frequently across domains, with 
some participants describing long- standing fears of dying 
during sleep.
Past research has examined the impact of diabetes on 
sex life20 and fear of hypoglycemia during sex for young 
adults with diabetes,21 but not the impact of hypogly-
cemia on sex life for adults with type 1 diabetes. Partici-
pants in this study felt less able to derive enjoyment and 
pleasure from sex due to (the risk of) hypoglycemia, and 
consequently, felt frustrated, embarrassed, insecure, and 
humiliated. When considered alongside other findings 
that hypoglycemia limits participation in and enjoyment 
of social interactions, this finding implies that hypogly-
cemia hinders an individual’s ability to relate to others 
in many ways.
Generic QoL measures typically assess other domains 
of QoL that were rarely mentioned by participants in the 
current study, including financial and spiritual factors,22 
although participants were not prompted to consider 
all QoL domains. With respect to financial impacts, the 
countries targeted in this study have universal healthcare 
systems, thus the impact of hypoglycemia on financial 
resources may be inherently lessened. There could be 
a greater impact of hypoglycemia on QoL in countries 
without universal healthcare systems.
The finding that positive support from others helps 
individuals to cope with the challenges of hypoglycemia 
indicates that the burden of hypoglycemia can be miti-
gated if support needs are met. While participants 
mentioned the benefits of diabetes technologies for 
hypoglycemia prevention, there were conflicting reports 
about the advantages of technologies for sleep, whereby 
CGM sensors allayed fears of nocturnal hypoglycemia but 
disrupted sleep with alarms. The finding that some partic-
ipants switch off their CGM alarms indicates that alarms 
are burdensome despite keeping participants safe.
Strengths and limitations
The ‘Wheel of Life’ was a key strength of this study as it 
provided a novel method for exploring areas of life that 
participants defined as important to their QoL, without 
researchers imposing a definition. While some partici-
pants reported minimal to no impact on certain domains, 
there was no mention of positive impacts of hypoglycemia, 
unlike previous studies in which people with diabetes 
have reported the benefits of diabetes management for 
healthy eating and exercise.20 23 However, the ‘Wheel 
of Life’ instructions prompted participants to consider 
the various impacts of hypoglycemia and included exam-
ples of challenges, so participants may have been more 
primed to consider negative impacts. Nonetheless, partic-
ipants could openly describe any type of impact relevant 
to their experience. The web- based format offered partic-
ipants the time to consider their responses carefully and 
allowed for lengthy and candid descriptions of sensitive 
issues (eg, sexuality). Conversely, researchers were unable 
to seek clarification of meaning, and some meaning may 
have been lost during translation.
While the web- based format enabled access to partici-
pants from multiple countries, this study may be subject 
to self- selection bias. There was an over- representation 
of participants with IAH, which may have further skewed 
responses toward reports of negative impacts. There 
was little mention of hypoglycemia awareness in qual-
itative responses, which may indicate that participants 
were not concerned about reduced awareness. While 
participants mentioned the impact of hypoglycemia on 
others (eg, CGM alarms being disruptive), it may be 
that they underestimate the impact of hypoglycemia on 
their relatives2 and the findings likely do not capture the 
full impact of hypoglycemia on relatives. The majority 
reported no severe episodes in the past year, which may 
imply that the impacts described do not refer solely to 
severe episodes and/or that severe episodes can have a 
long- standing impact. Future studies could differentiate 
between impacts of hypoglycemic episodes requiring the 
assistance of others versus episodes that are self- treated.
There was an over- representation of women in this 
sample, although quantitative analysis revealed minimal 
differences and free- text responses were not observed to 
be qualitatively different (eg, box 1). Further research 
is needed to examine the impact of hypoglycemia on 
QoL among men with type 1 diabetes, especially since 
there is evidence of gender differences in fear of hypo-
glycemia.24 This study may have been biased in terms of 
greater representation of socially advantaged people with 
internet access and social media engagement. Nonethe-
less, data were collected from a large, heterogeneous, 
multi- country (though mostly European) sample.
CONCLUSIONS
This study emphasizes the profound impact of hypo-
glycemia on areas of life that typically serve as an indi-
vidual’s resources, including their relationships and 
vocational activities. The findings indicate that hypogly-
cemia can interfere with basic human needs being met, 
from the physiological need for sleep to the social need 
for connection with others, which may account for the 
relationship between (fear of) hypoglycemia and mental 
health comorbidities.25 The ‘Wheel of Life’ was instru-
mental in eliciting rich personal accounts and should 
be used in future studies to determine whether these 
findings are corroborated in unselected and culturally 
diverse samples.
Despite the rise in tools to defend against hypogly-
cemia,26 27 adults with type 1 diabetes continue to report 
difficulties with hypoglycemia management. Main-
taining higher glucose levels to prevent hypoglycemia 
is common5 28–30 and can have serious health implica-
tions.31 The findings indicate that, beyond hypoglycemic 
episodes, fear of hypoglycemia and compensatory strat-
egies to prevent hypoglycemia can be disruptive and 
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hypoglycemia may not always reflect minimal impact on 
QoL. The findings can inform healthcare professionals’ 
understanding of the multifaceted impact of hypogly-
cemia on psychosocial functioning and diabetes self- 
care behaviors. Diabetes services should be aware of and 
address the burden of hypoglycemia to provide person- 
centered care. Clinicians could ask individuals how hypo-
glycemia affects important areas of their lives to better 
understand the personal impact, then facilitate access to 
tools and develop tailored hypoglycemia management 
plans accordingly.
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Supplemental Table S1. Comparison of Included and Excluded Participants on Core Demographic and Clinical Characteristics. 
 
 Included (n=219) Excluded (n=18) Between-Groups 
Difference 
Age (M, SD) 39.4 (13.3) 37.4 (13.5) p=.552 
Gender (Females; %, n) 83.1 (182) 55.6 (10) Fisher’s=8.349, p=.015 
Country of residence (%, n) 
Denmark 18.7 (41) 44.4 (8) p=.073 
Germany 23.3 (51) 11.1 (2) 
The Netherlands 30.1 (66) 22.2 (4) 
United Kingdom 27.9 (61) 22.2 (4) 
Current living situation (%, n) † 
Alone 16.0 (35) 5.6 (1) p=.236 
With spouse/partner 68.9 (151) 66.7 (12) p=.841 
With child(ren) 27.9 (61) 44.4 (8) p=.136 
With parent(s) 11.0 (24) 5.6 (1) p=.473 
Other 2.7 (6) 11.1 (2) p=.059 
Employment (%, n) † 
Full-time 42.0 (92) 38.9 (7) p=.796 
Part-time 23.3 (51) 11.1 (2) p=.233 
Self-employed 4.1 (9) 5.6 (1) p=.769 
Unemployed 5.9 (13) 11.1 (2) p=.386 
Unpaid worker 2.7 (6) 16.7 (3) p=.003* 
Student 16.4 (36) 22.2 (4) p=.529 
Retired 5.5 (12) 5.6 (1) p=.989 
Other 5.9 (13) 0.0 (0) p=.288 
Most recent educational qualification completed (%, n) † 
Secondary school or lower 15.5 (34) 16.7 (3) p=.683 
Further education 27.4 (60) 22.2 (4) p=.635 
Bachelor 30.6 (67) 38.9 (7) p=.465 
Master 21.5 (47) 16.7 (3) p=.632 
PhD 4.1 (9) 0.0 (0) p=.381 
Other 5.5 (12) 5.6 (1) p=.989 
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Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open Diab Res Care
 doi: 10.1136/bmjdrc-2021-002322:e002322. 9 2021;BMJ Open Diab Res Care, et al. Chatwin H
Frequency of hypoglycemia (Median, IQR) 
Number of episodes in past week  3.5 (2.0-6.0) 3.3 (3.0-5.3) p=.643 
≥1 Episode needing help from others in the 
past year 
32 (70) 35 (6) p=.778 
Hypoglycemia awareness status (%, n) 
Impaired (Gold score ≥4) 39.7 (87) 38.9 (7) p=.945 
HypoA-Q IA Subscale (M, SD) 7.6 (3.8) 7.7 (4.2) t=-0.083, p=.934 
Fear of hypoglycemia, HFS-SF Worry 
Subscale (M, SD)* 
10.5 (5.3) 13.9 (4.6) t=-2.568, p=.011 
HFS-SF = Hypoglycemia Fear Survey Short Form. 
* Higher scores indicate greater fear of hypoglycemia (out of a possible 24). 
† Participants were able to select more than one response option. 
Note: Between-group differences in annual net income, diabetes duration, treatment regimen, and comorbidities could not be examined due 
to missing data.     
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Supplemental Table S2. Participants’ Demographic, Clinical, and Psychological Characteristics. 
 













Age (M, SD) 39.4 (13.3) 40.2 (13.4) 37.8 (13.9) 36.5 (14.1)* 43.3 (10.8)* F=3.070, p=.029 
Gender (%, n) 
        Female 83.1 (182) 90.2 (37) 82.4 (42) 81.8 (54) 80.3 (49) p=.511 
Male 16.4 (36) 9.8 (4) 15.7 (8) 18.2 (12) 19.7 (12) 
Other 0.5 (1) 0.0 (0) 2.0 (1) 0.0 (0) 0.0 (0) 
Nationality (%, n) 
    Danish 18.3 (40) 95.1 (39) 2.0 (1) 0.0 (0) 0.0 (0) p<.001 
Dutch 29.7 (65) 2.4 (1) 0.0 (0) 97.0 (64) 0.0 (0) 
English 17.4 (38) 0.0 (0) 0.0 (0) 0.0 (0) 62.3 (38) 
German 21.9 (48) 0.0 (0) 94.1 (48) 0.0 (0) 0.0 (0) 
Indian 0.9 (2) 0.0 (0) 3.9 (2) 0.0 (0) 0.0 (0) 
Irish 2.3 (5) 0.0 (0) 0.0 (0) 0.0 (0) 8.2 (5) 
Moroccan 0.5(1) 0.0 (0) 0.0 (0) 1.5 (1) 0.0 (0) 
Romanian 0.5 (1) 0.0 (0) 0.0 (0) 1.5 (1) 0.0 (0) 
Scottish 5.9 (13) 2.4 (1) 0.0 (0) 0.0 (0) 19.7 (12) 
Welsh 0.9 (2) 0.0 (0) 0.0 (0) 0.0 (0) 3.3 (2) 
Other 1.4 (3) 0.0 (0) 0.0 (0) 0.0 (0) 4.9 (3) 
Most recent educational qualification completed (%, n) † 
Secondary school or 
lower 
15.1 (33) 17.1 (7) 17.6 (9) 13.6 (9) 13.1 (8) p=.880 
Further education 27.4 (60) 31.7 (13) 37.3 (19) 27.5 (18) 16.4 (10) p=.086 
Bachelor 30.6 (67)  17.1 (7)* 21.6 (11) 42.4 (28)* 34.4 (21) p=.016 
Master 21.5 (47) 24.4 (10)* 17.6 (9) 18.2 (12)* 26.2 (16) p=.595 
PhD 4.1 (9) 0.0 (0) 9.8 (5) 1.5 (1) 4.9 (3) p=.066 
Other 5.5 (12) 14.6 (6) 2.0 (1) 0.0 (0) 8.2 (5) p=.006 
Employment (%, n) † 
Full-time 42.0 (92) 43.9 (18) 43.1 (22) 24.2 (16)* 59.0 (36)* p=.001 
Part-time 23.3 (51) 9.8 (4)* 23.5 (12) 37.9 (25)* 16.4 (10) p=.003 
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Self-employed 4.1 (9) 0.0 (0) 0.0 (0) 10.6 (7) 3.3 (2) p=.011 
Unemployed 5.9 (13) 14.6 (6) 2.0 (1) 4.5 (3) 4.9 (3) p=.062 
Unpaid worker 2.7 (6) 2.4 (1) 2.0 (1) 6.1 (4) 0.0 (0) p=.205 
Student 16.4 (36) 12.2 (5) 19.6 (10) 21.2 (14) 11.5 (7) p=.377 
Retired 5.5 (12) 12.2 (5) 7.8 (4) 1.5 (1) 3.3 (2) p=.082 
Other 5.9 (13) 9.8 (4) 3.9 (2) 9.1 (6) 1.6 (1) p=.201 
Annual net income (%, n) 




























 ‡ 9.8 (4) 
Prefer not to say 
13.7 (7) 
Prefer not to say 
10.6 (7) 
Prefer not to say 
4.9 (3) 
Prefer not to say 
‡ 
Current living situation (%, n) † 
Alone 16.0 (35) 17.1 (7) 17.6 (9) 16.7 (11) 13.1 (8) p=.910 
With spouse/partner 68.9 (151) 68.3 (28) 70.6 (36) 60.6 (40) 77.0 (47) p=.252 
With child(ren) 27.9 (61) 24.4 (10) 25.5 (13) 25.8 (17) 34.4 (21) p=.606 
With parent(s) 11.0 (24) 4.9 (2) 13.7 (7) 18.2 (12) 4.9 (3) p=.051 
Other 2.7 (6) 0.0 (0) 0.0 (0) 6.1 (4) 3.3 (2) p=.145 
Diabetes duration (M, 
SD) 
20.4 (14.1) 18.8 (15.3)* 18.3 (14.3) 18.3 (12.2) 25.8 (14.1)* F=3.666, p=.013 
Treatment (%, n) † 
MDIs 47 (102) 68 (28)* 43 (22) 36 (24)* 46 (28) p=0.012 
Insulin pump 53 (116) 32 (13)* 57 (29) 65 (43)* 51 (31) p=0.008 
DIY 5 (11) 2 (1) 6 (3) 6 (4) 5 (3) p=0.851 
Frequency of hypoglycemia (HypoA-Q) 
Episodes in past week 
(Mdn, IQR) 
3.5 (2.0-6.0)* 3.0 (1.3-4.8) 4.0 (2.0-6.0) 4.0 (2.0-6.0) 4.0 (3.0-7.0)* F=2.795, p=.041 
≥1 Episode needing 
help from others in the 
32.0 (70) 24.4 (10) 39.2 (20) 36.4 (24) 26.2 (16) p=.284 
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past year (%, n) 
Frequency of self-treated episodes in past 12 months (%, n) 
Never 1.4 (3) 2.4 (1) 2.0 (1) 0.0 (0) 1.6 (1) p=.276 
1-2 times 1.8 (4) 2.4 (1) 3.9 (2) 0.0 (0) 1.6 (1) 
3-4 times 3.7 (8) 4.9 (2) 3.9 (2) 4.5 (3) 1.6 (1) 
1-2 times/month 14.2 (31) 24.4 (10) 9.8 (5) 18.2 (12) 6.6 (4) 
1 time/week 16.9 (37) 19.5 (8) 23.5 (12) 12.1 (8) 14.8 (9) 
1+ times/week 62.1 (136) 46.3 (19) 56.9 (29) 65.2 (43) 73.8 (45) 
Hypoglycemia awareness status 
Gold Score 
M (SD) 3.4 (1.7) 3.5 (1.9) 3.2 (1.5) 3.4 (1.5) 3.3 (1.7) p=.706 
Impaired (Gold ≥4) 
(%, n) 
39.7 (87) 46.3 (19) 31.4 (16) 40.9 (27) 41.0 (35) p=.510 
HypoA-Q IA Scale 
(M, SD) § 
7.8 (4.4) 7.4 (4.9) 7.2 (4.2) 8.3 (4.0) 8.2 (4.7) F=0.824, p=.482 
Comorbidities (%, n) † 
Diabetes-related 3.8 (9) 0.0 (0) 5.2 (3) 4.2 (3) 4.5 (3) p=.139 
Other || 47.5 (114) 57.8 (26) 44.8 (26) 34.7 (31) 47.0 (31) 
None 47.5 (114) 42.2 (19) 44.8 (26) 52.1 (37) 48.5 (32) 
Prefer not to say 1.3 (3) 0.0 (0) 5.2 (3) 0.0 (0) 0.0 (0) 
Fear of hypoglycemia: 
HFS-SF Worry Scale 
(M, SD) ¶ 
10.5 (5.3) 10.5 (5.4) 11.7 (5.9) 9.9 (5.1) 10.1 (4.7) p=.277 
Adapted DIDP: Impact of COVID-19 pandemic on QoL # 
Total Score 3.3 (0.8) 3.2 (0.6) 3.3 (0.77) 3.5 (0.8) 3.2 (0.8) p=.078 
Diabetes 3.6 (1.3) 3.4 (1.0) 3.8 (1.35) 3.8 (1.0) 3.3 (1.5) p=.090 
Sleep 3.6 (1.2) 3.5 (0.8) 3.8 (1.14) 3.9 (1.2)* 3.3 (1.2)* p=.019 
Health 3.7 (1.2) 3.6 (0.9) 3.8 (1.22) 3.9 (1.3)* 3.4 (1.4)* p=.129 
Wellbeing 3.0 (1.2) 3.0 (0.9) 3.0 (1.32) 3.3 (1.2) 2.9 (1.2) p=.197 
Finance 3.7 (1.1) 3.7 (0.9) 3.5 (1.16) 3.9 (0.9) 3.8 (1.3) p=.300 
Relationship 3.3 (1.2) 3.0 (1.1) 3.1 (1.25) 3.4 (1.2) 3.6 (1.3) p=.064 
Leisure 2.8 (1.4) 2.6 (1.2) 2.7 (1.43) 3.1 (1.3) 2.6 (1.5) p=.163 
Work 3.1 (1.4) 2.7 (1.1) 3.1 (1.54) 3.2 (1.3) 3.1 (1.4) p=.330 
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Future 3.0 (1.1) 2.8 (1.1) 3.1 (1.17) 3.4 (1.1) 2.8 (1.0) p=.018 
Between-country differences were analyzed using one-way ANOVAs and Chi-square tests. DIDP = DAWN2 Impact of Diabetes Profile; 
HypoA-Q = Hypoglycaemia Awareness Questionnaire; HFS-SF = Hypoglycemia Fear Survey Short Form; IA = Impaired Awareness; 
MDIs = Multiple daily injections; DIY = Do-it-yourself technologies (e.g., closed-loop systems). 
* Group implicated in statistically significant difference. 
† Participants were able to select more than one response option. 
‡ Cannot be calculated due to inequivalent country-specific income brackets. 
§ Higher scores indicate greater self-reported impairment of hypoglycemia awareness (out of a possible 20). 
|| Other comorbidities include autoimmune conditions, psychiatric conditions, and other physical health problems. 
¶ Higher scores indicate greater fear of hypoglycemia (out of a possible 24). 
# Lower scores indicate more significant negative impact (1 = Very negative impact to 7 = Very positive impact)  
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Supplemental Table S3. Between-Country Differences in the Number of Times QoL Domains were Nominated by Participants. 
QoL Domain Overall Denmark Germany Netherlands United Kingdom Between-Country 
Difference 
Relationships and Social Life 233 44 59 63 67 p=.527 
Work and Study 176 31 41 61 43 p=.341 
Leisure and Physical Activity 175 27 47 54 47 p=.899 
Everyday Life 137 16 36 46 39 p=.405 
Sleep 80 12 19 17 32 p=.086 
Sex Life 34 6 12 11 5 p=.275 
Physical Health 24 5 3 7 9 p=.456 
Mental Health 10 1 2 2 5 p=.502 
Note that QoL domains may have been nominated several times by a single participant, where they referred to that domain in different 
ways across entries (e.g., “Work meetings”, “Working life”, and “Talks with colleagues”). 
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Supplemental Table S4. Gender Differences in the Number of Times QoL Domains were Nominated. 
 
QoL Domain Overall Female Male Between-Groups Difference 
Relationships and Social Life 233 206 27 p=.034* 
Work and Study 175 145 30 p=.625 
Leisure and Physical Activity 174 142 32 p=.322 
Everyday Life 136 115 21 p=.864 
Sleep 80 69 11 p=.575 
Sex Life 34 25 9 p=.087 
Physical Health 24 19 5 p=.506 
Mental Health 10 7 3 p=.222 
Note that QoL domains may have been nominated several times by a single participant, where they referred to that domain in different 
ways across entries (e.g., “Work meetings”, “Working life”, and “Talks with colleagues”). 
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Supplemental Table S5. Between-Groups Differences in the Number of Times QoL Domains were Nominated. 
 
QoL Domain Overall Severe Hypoglycemia 
Past Year 




Relationships and Social Life 233 79 154 p=.408 
Work and Study 176 64 112 p=.943 
Leisure and Physical Activity 175 62 113 p=.828 
Everyday Life 137 51 86 p=.772 
Sleep 80 30 50 p=.789 
Sex Life 34 16 18 p=.176 
Physical Health 24 10 14 p=.567 
Mental Health 10 8 2 p=.285 
Note that QoL domains may have been nominated several times by a single participant, where they referred to that domain in different 
ways across entries (e.g., “Work meetings”, “Working life”, and “Talks with colleagues”). 
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Domain / Country Overall Denmark Germany Netherlands UK Between-Country Difference 
Relationships and Social Life 141 36 31 38 36 p=.064 
Work and Study 148 25 39 50 34 p=.153 
Leisure and Physical Activity 122 15 40* 41 26 p=.040* 
Everyday Life 89 13 26 30 20 p=.557 
Sleep 62 8 20 15 19 p=.470 
Sex Life 24 5 9 6 4 p=.278 
Physical Health 14 2 3 6 3 p=.752 
Mental Health 35 7 3 18* 7 p=.021* 
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Domain / Gender Overall Females Males Between-Groups Difference 
Relationships and Social Life 105 88 17 p=.901 
Work and Study 120 106* 14 p=.033* 
Leisure and Physical Activity 93 77 16 p=.813 
Everyday Life 70 58 12 p=.863 
Sleep 55 50 5 p=.086 
Sex Life 24 17 7 p=.077 
Physical Health 14 13 1 p=.329 
Mental Health 26 22 4 p=.869 
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Domain / Gender Overall Severe Hypoglycemia 
Past Year 




Relationships and Social Life 105 41 64 p=.379 
Work and Study 121 50 71 p=.072 
Leisure and Physical Activity 94 36 58 p=.552 
Everyday Life 70 20 50 p=.113 
Sleep 55 18 37 p=.550 
Sex Life 24 13 11 p=.050* 
Physical Health 14 7 7 p=.262 
Mental Health 27 10 17 p=.911 
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